Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01854606. IPD Sharing: NO. Countries: 8. Publications: 0.
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
ClinicalTrials.gov study NCT06533059. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05017025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
ClinicalTrials.gov study NCT02251314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03122717. IPD Sharing: NO. Countries: 1. Publications: 0.
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
ClinicalTrials.gov study NCT05933668. IPD Sharing: NO. Countries: 1. Publications: 0.
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
ClinicalTrials.gov study NCT01611675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Effects of PEITC on Oral Cells With Mutant p53
ClinicalTrials.gov study NCT01790204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid Tumors
ClinicalTrials.gov study NCT04892017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
ClinicalTrials.gov study NCT07193394. IPD Sharing: YES. Countries: 1. Publications: 0.
An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib
ClinicalTrials.gov study NCT05451056. IPD Sharing: NO. Countries: 1. Publications: 0.
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
ClinicalTrials.gov study NCT03855371. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW
ClinicalTrials.gov study NCT06355609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors
ClinicalTrials.gov study NCT02746081. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
ClinicalTrials.gov study NCT05465343. IPD Sharing: NO. Countries: 1. Publications: 0.
VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05489731. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML
ClinicalTrials.gov study NCT03642236. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03777124. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01274624. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
ClinicalTrials.gov study NCT05638295. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.